Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · IEX Real-Time Price · USD
23.80
+0.39 (1.67%)
Sep 30, 2022 4:00 PM EDT - Market closed
1.67%
Market Cap 347.48M
Revenue (ttm) 151.71M
Net Income (ttm) -11.01M
Shares Out 14.60M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE 78.74
Dividend n/a
Ex-Dividend Date n/a
Volume 138,484
Open 23.23
Previous Close 23.41
Day's Range 23.23 - 24.30
52-Week Range 19.95 - 45.81
Beta 1.00
Analysts Buy
Price Target 46.92 (+97.1%)
Earnings Date Nov 2, 2022

About ANIK

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide ... [Read more...]

Industry Biotechnology
IPO Date Apr 29, 1993
CEO Joseph Darling
Employees 297
Stock Exchange NASDAQ
Ticker Symbol ANIK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for ANIK stock is "Buy." The 12-month stock price forecast is 46.92, which is an increase of 97.14% from the latest price.

Price Target
$46.92
(97.14% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release

X-Twist expands Anika's sports medicine portfolio with a cornerstone suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities X-Twist expands Anika's sports medi...

2 weeks ago - GlobeNewsWire

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 23.08% and 8.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Anika Reports Second Quarter Fiscal 2022 Financial Results

Second quarter revenue growth up 4% X-Twist ™ 510(k) clearance received; Limited market release on schedule for 2H 2022

1 month ago - GlobeNewsWire

Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American O...

BEDFORD, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has rece...

2 months ago - GlobeNewsWire

Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022

BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans t...

2 months ago - GlobeNewsWire

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will par...

3 months ago - GlobeNewsWire

Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tis...

X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities X-Twist provides a simple, versatile knotless suture ancho...

4 months ago - GlobeNewsWire

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022, Anik...

4 months ago - GlobeNewsWire

Anika to Participate in the UBS Global Healthcare Conference 2022

BEDFORD, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will part...

4 months ago - GlobeNewsWire

Anika Reports First Quarter Fiscal 2022 Financial Results

First quarter revenue growth of 7% year-over-year driven by favorable order timing in OA Pain Management First quarter revenue growth of 7% year-over-year driven by favorable order timing in OA Pain Man...

4 months ago - GlobeNewsWire

New Strong Sell Stocks for April 26th

ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022

Other symbols: ADAPALIM
5 months ago - Zacks Investment Research

New Strong Sell Stocks for April 19th

ANIK, APP, and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2022.

Other symbols: APPARCE
5 months ago - Zacks Investment Research

Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022

BEDFORD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans ...

5 months ago - GlobeNewsWire

New Strong Sell Stocks for April 7th

AMPE, ANIK, and FAT have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2022.

Other symbols: AMPEFAT
5 months ago - Zacks Investment Research

Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference

BEDFORD, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will pa...

5 months ago - GlobeNewsWire

New Strong Sell Stocks for April 4th

AKU, ANIK, and AY have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2022.

Other symbols: AKUAY
5 months ago - Zacks Investment Research

New Strong Sell Stocks for March 28th

ALIM, ANIK, and APPF have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2022

Other symbols: ALIMAPPF
6 months ago - Zacks Investment Research

Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting

Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management, regenerative solutions, sports medicine, and bone preservin...

6 months ago - GlobeNewsWire

New Strong Sell Stocks for March 21st

ARAY, AKU, and ANIK have been added to the Zacks Rank #5 (Strong Sell) List on March 21, 2022

Other symbols: AKUARAY
6 months ago - Zacks Investment Research

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will pa...

6 months ago - GlobeNewsWire

Anika Reports Fourth Quarter and Year-End 2021 Financial Results

Fourth quarter revenue growth of 10% year-over-year despite COVID headwinds Full-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration

6 months ago - GlobeNewsWire

Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022

BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans t...

7 months ago - GlobeNewsWire

Anika to Participate in Upcoming Investor Conferences

BEDFORD, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchar...

10 months ago - GlobeNewsWire

Anika Therapeutics (ANIK) Tops Q3 Earnings and Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 144.44% and 8.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

Anika Appoints Sheryl Conley to Board of Directors

Appointment brings experienced orthopedic industry commercial leader to Anika's Board Appointment brings experienced orthopedic industry commercial leader to Anika's Board

11 months ago - GlobeNewsWire